| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4026117 | Ophthalmology | 2014 | 10 Pages |
Abstract
At 36 months, there was a sustained improvement in Kmax, UCVA, and BSCVA after CXL, whereas eyes in the control group demonstrated further progression.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Christine MD, Elsie FRANZCO, Fakir M.A. PhD, Tony BSc, BOrth&OphSc, Mark FRANZCO, Grant R. FRANZCO,